On May 7, 2021, the inactivated COVID-19 vaccines developed and produced by Sinopharm CNBG's Beijing Institute of Biological Products received emergency use authorization from the World Health Organization.
Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing
On May 7, 2021, the inactivated COVID-19 vaccines developed and produced by Sinopharm CNBG's Beijing Institute of Biological Products received emergency use authorization from the World Health Organization.